From a clinical Hematology perspective, ensuring the rapid restoration of red blood cell counts is vital for preventing chronic anemia in the elderly
CONCLUSIONS CONFLICTS OF INTEREST In the last 5 years Adie Viljoen has received lecture honoraria and/or travel support and/or conducts clinical trials funded by: Amarin, Amgen, Astra Zeneca, Boehringer Ingleheim, Daiichi-Sankyo, Lilly, Menarini, NewAmsterdam, Novartis, Novo Nordisk, Pfizer, Regeneron, Sanofi, Takeda, and Tosoh
For some, this can be a more comfortable option with less potential for soreness at the injection site
GHK-Cu may reduce the sensitivity of hair follicles to DHT without actually lowering hormone levels
Animal use and opportunities for reduction in carcinogenicity studies supporting approved new drug applications in the U.S., 20152019